  <page>
    <title>Central pontine myelinolysis</title>
    <ns>0</ns>
    <id>7846</id>
    <revision>
      <id>942969646</id>
      <parentid>942969604</parentid>
      <timestamp>2020-02-28T00:49:30Z</timestamp>
      <contributor>
        <ip>86.165.197.23</ip>
      </contributor>
      <model>wikitext</model>
      <format>text/x-wiki</format>
      <text xml:space="preserve">{{Infobox medical condition (new)
| name            = Central pontine myelinolysis
| synonyms        = Osmotic demyelination syndrome, central pontine demyelination
| image           = MRI Central Pontine Myelinolysis fat sat T2.jpg
| alt             = 
| caption         = Axial fat-saturated T2-weighted image showing hyperintensity in the pons with sparing of the peripheral fibers, the patient was an alcoholic admitted with a serum Na of 101 treated with hypertonic saline, he was left with quadreparesis, dysarthria, and altered mental status
| pronounce       = 
| field           = [[Neurology]]
| symptoms        = 
| complications   = 
| onset           = 
| duration        = 
| types           = 
| causes          = 
| risks           = 
| diagnosis       = 
| differential    = 
| prevention      = 
| treatment       = 
| medication      = 
| prognosis       = 
| frequency       = 
| deaths          = 
}}

'''Central pontine myelinolysis''' ('''CPM''') is a neurological condition involving severe damage to the [[myelin sheath]] of [[neuron|nerve cells]] in the ''[[pons]]'' (an area of the [[brainstem]]). It is predominately [[iatrogenic]] (treatment-induced), and is characterized by acute paralysis,  [[dysphagia]] (difficulty swallowing), [[dysarthria]] (difficulty speaking), and other neurological symptoms.

Central pontine myelinolysis was first described as a disorder in 1959. The original paper described four cases with fatal outcomes, and the findings on autopsy. The disease was described as a disease of alcoholics and malnutrition.&lt;ref name=&quot;Yoon&quot;/&gt; ‘Central pontine’ indicated the site of the lesion and ‘myelinolysis’ was used to emphasise that myelin was affected. The authors intentionally avoided the term ‘demyelination’ to describe the condition, in order to differentiate this condition from multiple sclerosis and other neuroinflammatory disorders.&lt;ref name=&quot;pmid21949915&quot;&gt;{{cite journal|last1=Bose|first1=P|last2=Kunnacherry|first2=A|last3=Maliakal|first3=P|title=Central pontine myelinolysis without hyponatraemia|journal=The Journal of the Royal College of Physicians of Edinburgh|date=19 September 2011|volume=41|issue=3|pages=211–214|doi=10.4997/JRCPE.2011.305|doi-access=free|pmid=21949915}}&lt;/ref&gt;

Since this original description, demyelination in other areas of the central nervous system associated with osmotic stress has been described outside the pons (extrapontine).&lt;ref name=&quot;pmid3322623&quot;&gt;{{cite journal |vauthors=Gocht A, Colmant HJ |title=Central pontine and extrapontine myelinolysis: a report of 58 cases |journal=Clin. Neuropathol. |volume=6 |issue=6 |pages=262–70 |year=1987 |pmid=3322623 |doi= |url=}}&lt;/ref&gt; '''Osmotic demyelination syndrome''' ('''ODS''') is the term used for both central pontine myelinolysis and extrapontine myelinolysis.&lt;ref name=&quot;pmid11803185&quot;&gt;{{cite journal |vauthors=Lampl C, Yazdi K |title=Central pontine myelinolysis |journal=Eur. Neurol. |volume=47 |issue=1 |pages=3–10 |year=2002 |pmid=11803185 |doi=10.1159/000047939 |url=http://content.karger.com/produktedb/produkte.asp?typ=fulltext&amp;file=ene47003 |archiveurl=https://web.archive.org/web/20120306022240/http://content.karger.com/produktedb/produkte.asp?typ=fulltext&amp;file=ene47003 |archivedate=2012-03-06 |url-status=live }}&lt;/ref&gt;

Central pontine myelinolysis, and osmotic demyelination syndrome, present most commonly as a complication of treatment of patients with profound [[hyponatremia]] (low [[sodium]]), which can result from a varied spectrum of conditions, based on different mechanisms. It occurs as a consequence of a rapid rise in [[serum (blood)|serum]] [[tonicity]] following treatment in individuals with chronic, severe hyponatremia who have made intracellular adaptations to the prevailing hypotonicity.&lt;ref name=&quot;babar&quot;&gt;{{cite journal |pmid=24259701 |date=October 2013 |last1=Babar |first1=S. |title=SIADH Associated With Ciprofloxacin. |volume=47 |issue=10 |pages=1359–1363 |issn=1060-0280 |journal=Annals of Pharmacotherapy |doi=10.1177/1060028013502457 |pmc= |df=mdy-all }}&lt;/ref&gt;&lt;ref&gt;https://academic.oup.com/alcalc/article/43/6/647/249472&lt;/ref&gt;

==Signs and symptoms== 
[[File:Extrapontine myelinolysis T2 01.jpg|thumb|T2 weighted magnetic resonance scan image showing bilaterally symmetrical hyperintensities in [[caudate nucleus]] (small, thin arrow), [[putamen]] (long arrow), with sparing of [[globus pallidus]] (broad arrow), suggestive of extrapontine myelinolysis (osmotic demyelination syndrome)]]

Symptoms depend on the regions of the brain involved. Prior to its onset, patients may present with the neurological signs and symptoms of hyponatraemic encephalopathy such as nausea and vomiting, confusion, headache and seizures. These symptoms may resolve with normalisation of the serum sodium concentration. Three to five days later, a second phase of neurological manifestations occurs correlating with the onset of myelinolysis. Observable immediate precursors may include seizures, disturbed consciousness, gait changes, and decrease or cessation of respiratory function.&lt;ref name=&quot;pmid16218318&quot;&gt;{{cite journal|vauthors=Musana AK, Yale SH|date=August 2005|title=Central pontine myelinolysis: case series and review|url=|journal=WMJ|volume=104|issue=6|pages=56–60|doi=|pmid=16218318}}&lt;!--|accessdate=2014-05-29--&gt;&lt;/ref&gt;&lt;ref&gt;{{cite journal| pmid = 20148334 | doi=10.1007/s00415-010-5486-7 | volume=257 | issue=7 | title=Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis |date=July 2010 |vauthors=Odier C, Nguyen DK, Panisset M | journal=J. Neurol. | pages=1176–80}}&lt;/ref&gt;

The classical clinical presentation is the progressive development of spastic [[quadriparesis]], [[pseudobulbar palsy]], and emotional lability ([[pseudobulbar affect]]), with other more variable neurological features associated with brainstem damage. These result from a rapid myelinolysis of the [[corticobulbar]] and [[corticospinal]] tracts in the brainstem.&lt;ref name=&quot;pmid8231786&quot;&gt;{{cite journal|vauthors=Karp BI, Laureno R|date=November 1993|title=Pontine and extrapontine myelinolysis: a neurologic disorder following rapid correction of hyponatremia|url=|journal=Medicine (Baltimore)|volume=72|issue=6|pages=359–73|doi=10.1097/00005792-199311000-00001|pmid=8231786}}&lt;!--|accessdate=2014-05-29--&gt;&lt;/ref&gt;

In about ten per cent of people with CPM, extrapontine myelinolysis (EPM) is also found. In these cases symptoms of [[Parkinson's disease]] may be generated.&lt;ref name=&quot;Yoon&quot;/&gt;

==Causes==
[[File:Pontine myelinolysis.jpg|thumb|right|Loss of myelinated fibers at the [[basilar part of the pons]] in the brainstem (Luxol-Fast blue stain)]]
The most common cause is overly rapid correction of low blood sodium levels ([[hyponatremia]]).&lt;ref name=&quot;pmid10544728&quot;&gt;{{cite journal |vauthors=Bernsen HJ, Prick MJ |title=Improvement of central pontine myelinolysis as demonstrated by repeated magnetic resonance imaging in a patient without evidence of hyponatremia |journal=Acta Neurol Belg |volume=99 |issue=3 |pages=189–93 |date=September 1999 |pmid=10544728 |doi= |url=}}&lt;/ref&gt; Apart from rapid correction of hyponatraemia, there are case reports of central pontine myelinolysis in association with hypokalaemia, anorexia nervosa when feeding is started, patients undergoing dialysis and burn victims. There is a case report of central pontine myelinolysis occurring in the context of re-feeding syndrome, in the absence of hyponatremia.&lt;ref name=&quot;pmid21949915&quot;/&gt;

It has also been known to occur in patients suffering withdrawal symptoms of chronic [[alcoholism]].&lt;ref name=&quot;Yoon&quot;&gt;{{cite journal |vauthors=Yoon B, Shim YS, Chung SW | year = 2008 | title = Central Pontine and Extrapontine Myelinolysis After Alcohol Withdrawal | url = http://alcalc.oxfordjournals.org/content/43/6/647.full | journal = Alcohol | volume = 43 | issue = 6| pages = 647–9 | doi=10.1093/alcalc/agn050| pmid = 18678596 }}&lt;/ref&gt;  In these instances, occurrence may be entirely unrelated to hyponatremia or rapid correction of hyponatremia. It could affect patients who take some prescription medicines that are able to cross the [[Blood–brain barrier|blood-brain barrier]] and cause abnormal thirst reception - in this scenario the CPM is caused by [[polydipsia]] leading to low blood sodium levels (hyponatremia).

In [[Schizophrenia|schizophrenic]] patients with [[Primary polydipsia|psychogenic polydipsia]], inadequate thirst reception leads to excessive water intake, severely diluting serum sodium.&lt;ref&gt;{{Cite web|url=http://www.apadivisions.org/division-31/publications/articles/british-columbia/psychogenic-polydipsia.pdf|title=Psychogenic Polydipsia (Excessive Fluid seeking Behaviour)|last=Donald|first=Hutcheon|date=|website=|publisher=American Psychological Society Divisions|access-date=}}&lt;/ref&gt; With this excessive thirst combined with psychotic symptoms, brain damage such as CPM&lt;ref&gt;{{Cite journal|last=Lim|first=Leslie|last2=Krystal|first2=Andrew|date=2007-06-01|title=Psychotic disorder in a patient with central and extrapontine myelinolysis|journal=Psychiatry and Clinical Neurosciences|language=en|volume=61|issue=3|pages=320–322|doi=10.1111/j.1440-1819.2007.01648.x|pmid=17472602|issn=1440-1819}}&lt;/ref&gt; may result from [[Osmotic concentration|hyperosmolarity]] caused by excess intake of fluids, ([[primary polydipsia]]) although this is difficult to determine because such patients are often [[institutionalised]] and have a long history of mental health conditions.&lt;ref&gt;{{Cite journal|last=Melissa|first=Gill|last2=MacDara|first2=McCauley|last3=Melissa|first3=Gill|last4=MacDara|first4=McCauley|date=2015-01-21|title=Psychogenic Polydipsia: The Result, or Cause of, Deteriorating Psychotic Symptoms? A Case Report of the Consequences of Water Intoxication|journal=Case Reports in Psychiatry|language=en|volume=2015|pages=846459|doi=10.1155/2015/846459|issn=2090-682X|pmc=4320790|pmid=25688318}}&lt;/ref&gt;

It has been observed following [[hematopoietic stem cell transplantation]].&lt;ref name=&quot;pmid18437020&quot;&gt;{{cite journal |vauthors=Lim KH, Kim S, Lee YS |display-authors=etal |title=Central pontine myelinolysis in a patient with acute lymphoblastic leukemia after hematopoietic stem cell transplantation: a case report |journal=J. Korean Med. Sci. |volume=23 |issue=2 |pages=324–7 |date=April 2008 |pmid=18437020 |pmc=2526450 |doi=10.3346/jkms.2008.23.2.324 |url=http://jkms.org/contents/jkms.php?pubyear=2008&amp;vol=23&amp;fpage=324|archive-url=https://web.archive.org/web/20090227043351/http://jkms.org/contents/jkms.php?pubyear=2008&amp;vol=23&amp;fpage=324|url-status=dead|archive-date=2009-02-27}}&lt;/ref&gt;

CPM may also occur in patients prone to hyponatraemia affected by:
* Severe liver disease (e.g., [[cirrhosis]])
* Liver transplant&lt;ref name=&quot;pmid8152365&quot;&gt;{{cite journal|vauthors=Singh N, Yu VL, Gayowski T|date=March 1994|title=Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management|url=|journal=Medicine (Baltimore)|volume=73|issue=2|pages=110–8|doi=10.1097/00005792-199403000-00004|pmid=8152365}}&lt;!--|accessdate=2014-05-29--&gt;&lt;/ref&gt;&lt;ref name=&quot;pmid11934516&quot;&gt;{{cite journal |vauthors=Kato T, Hattori H, Nagato M, Kiuchi T, Uemoto S, Nakahata T, Tanaka K |title=Subclinical central pontine myelinolysis following liver transplantation |journal=Brain Dev. |volume=24 |issue=3 |pages=179–82 |date=April 2002  |pmid=11934516 |doi= 10.1016/S0387-7604(02)00013-X}}&lt;/ref&gt;&lt;ref name=&quot;pmid3047544&quot;&gt;{{cite journal|vauthors=Martinez AJ, Estol C, Faris AA|date=May 1988|title=Neurologic complications of liver transplantation|url=|journal=Neurol Clin|volume=6|issue=2|pages=327–48|doi=10.1016/S0733-8619(18)30873-9|pmid=3047544}}&lt;!--|accessdate=2014-05-29--&gt;&lt;/ref&gt;
* [[Alcohol use disorder|Alcoholism]]
* [[Hypokalemia]]
* People with serum sodium &lt;105 mEq/L
* Severe burns&lt;ref name=&quot;pmid3399069&quot;&gt;{{cite journal|vauthors=McKee AC, Winkelman MD, Banker BQ|date=August 1988|title=Central pontine myelinolysis in severely burned patients: relationship to serum hyperosmolality|url=|journal=Neurology|volume=38|issue=8|pages=1211–7|doi=10.1212/wnl.38.8.1211|pmid=3399069}}&lt;!--|accessdate=2014-05-29--&gt;&lt;/ref&gt;&lt;ref name=&quot;pmid1522803&quot;&gt;{{cite journal|vauthors=Winkelman MD, Galloway PG|date=September 1992|title=Central nervous system complications of thermal burns. A postmortem study of 139 patients|url=|journal=Medicine (Baltimore)|volume=71|issue=5|pages=271–83|doi=10.1097/00005792-199209000-00002|pmid=1522803}}&lt;!--|accessdate=2014-05-29--&gt;&lt;/ref&gt;
* [[Malnutrition]]
* [[Anorexia nervosa]]&lt;ref name=&quot;pmid12588925&quot;&gt;{{cite journal |vauthors=Sugimoto T, Murata T, Omori M, Wada Y |title=Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa |journal=J. Neurol. Neurosurg. Psychiatry |volume=74 |issue=3 |pages=353–5 |date=March 2003  |pmid=12588925 |pmc=1738317 |doi= 10.1136/jnnp.74.3.353}}&lt;/ref&gt;&lt;ref name=&quot;pmid15026526&quot;&gt;{{cite journal |author=Keswani SC |title=Central pontine myelinolysis associated with hypokalaemia in anorexia nervosa |journal=J. Neurol. Neurosurg. Psychiatry |volume=75 |issue=4 |pages=663; author reply 663 |date=April 2004  |pmid=15026526 |pmc=1739009 |doi= |url=http://jnnp.bmj.com/cgi/pmidlookup?view=long&amp;pmid=15026526 |accessdate=2014-05-29}}&lt;/ref&gt;&lt;ref name=&quot;pmid22473289&quot;&gt;{{cite journal |vauthors=Leroy S, Gout A, Husson B, de Tournemire R, Tardieu M |title=Centropontine myelinolysis related to refeeding syndrome in an adolescent suffering from anorexia nervosa |journal=Neuropediatrics |volume=43 |issue=3 |pages=152–4 |date=June 2012  |pmid=22473289 |doi=10.1055/s-0032-1307458 }}&lt;/ref&gt;
* Severe electrolyte disorders
* [[HIV/AIDS]]
*[[hyperemesis gravidarum]]&lt;ref name=&quot;pmid1393001&quot;&gt;{{cite journal |vauthors=Bergin PS, Harvey P |title=Wernicke's encephalopathy and central pontine myelinolysis associated with hyperemesis gravidarum |journal=BMJ |volume=305 |issue=6852 |pages=517–8 |date=August 1992  |pmid=1393001 |pmc=1882865 |doi= 10.1136/bmj.305.6852.517|url= }}&lt;/ref&gt;&lt;ref name=&quot;pmid23546346&quot;&gt;{{cite journal |vauthors=Sutamnartpong P, Muengtaweepongsa S, Kulkantrakorn K |title=Wernicke's encephalopathy and central pontine myelinolysis in hyperemesis gravidarum |journal=J Neurosci Rural Pract |volume=4 |issue=1 |pages=39–41 |date=January 2013  |pmid=23546346 |pmc=3579041 |doi=10.4103/0976-3147.105608 }}&lt;/ref&gt;
* Hyponatremia due to [[peritoneal dialysis]]
* [[Wernicke encephalopathy]]&lt;ref name=&quot;pmid22728498&quot;&gt;{{cite journal |vauthors=Kishimoto Y, Ikeda K, Murata K, Kawabe K, Hirayama T, Iwasaki Y |title=Rapid development of central pontine myelinolysis after recovery from Wernicke encephalopathy: a non-alcoholic case without hyponatremia |journal=Intern. Med. |volume=51 |issue=12 |pages=1599–603 |year=2012 |pmid=22728498 |doi= 10.2169/internalmedicine.51.7498}}&lt;/ref&gt;

==Pathophysiology==
The currently accepted theory states that the brain cells adjust their [[osmolarity|osmolarities]] by changing levels of certain osmolytes like [[inositol]], [[betaine]], and [[glutamine]] in response to varying serum osmolality. In the context of [[Chronic (medicine)|chronic]] low plasma sodium (hyponatremia), the brain compensates by decreasing the levels of these osmolytes within the cells, so that they can remain relatively isotonic with their surroundings and not absorb too much fluid. The reverse is true in hypernatremia, in which the cells increase their intracellular osmolytes so as not to lose too much fluid to the extracellular space.

With correction of the hyponatremia with [[intravenous fluids]], the extracellular tonicity increases, followed by an increase in intracellular tonicity. When the correction is too rapid, not enough time is allowed for the brain's cells to adjust to the new tonicity, namely by increasing the intracellular osmoles mentioned earlier. If the serum sodium levels rise too rapidly, the increased extracellular tonicity will continue to drive water out of the brain's cells. This can lead to cellular dysfunction and CPM.&lt;ref name=&quot;pmid12566274&quot;&gt;{{cite journal|vauthors=Medana IM, Esiri MM |title=Axonal damage: a key predictor of outcome in human CNS diseases|journal=Brain|volume=126|issue=Pt 3|pages=515–30|date=March 2003|pmid=12566274|doi=10.1093/brain/awg061|url=http://brain.oxfordjournals.org/cgi/pmidlookup?view=long&amp;pmid=12566274}}&lt;/ref&gt;&lt;ref name=&quot;pmid24569125&quot;&gt;{{cite journal|vauthors=Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, Decaux G, Fenske W, Hoorn E, Ichai C, Joannidis M, Soupart A, Zietse R, Haller M, van der Veer S, Van Biesen W, Nagler E |title=Clinical practice guideline on diagnosis and treatment of hyponatremia|journal=European Journal of Endocrinology|volume=170|issue=3|pages=G1–G47|date=2014|doi=10.1530/eje-13-1020|pmid=24569125}}&lt;/ref&gt;

==Diagnosis==
It can be diagnosed clinically in the appropriate context, but may be difficult to confirm radiologically using conventional imaging techniques.  Changes are more prominent on MRI than on CT, but often take days or weeks after acute symptom onset to develop. Imaging by [[Magnetic resonance imaging|MRI]] typically demonstrates areas of hyperintensity on T2-weighted images.

==Treatment==
To minimise the risk of this condition developing from its most common cause, overly rapid reversal of hyponatremia, the hyponatremia should be corrected at a rate not exceeding 10&amp;nbsp;mmol/L/24&amp;nbsp;h or 0.5&amp;nbsp;mEq/L/h; or 18 mEq/L/48hrs; thus avoiding demyelination.&lt;ref name=&quot;pmid24569125&quot; /&gt; No large clinical trials have been performed to examine the efficacy of therapeutic re-lowering of serum sodium, or other interventions sometimes advocated such as steroids or plasma exchange.&lt;ref name=&quot;pmid24569125&quot; /&gt; 
Alcoholic patients should receive vitamin supplementation and a formal evaluation of their nutritional status.&lt;ref&gt;{{cite journal | pmid = 7466381 | volume=211 | issue=4486 | title=Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis |date=March 1981 |vauthors=Kleinschmidt-DeMasters BK, Norenberg MD | journal=Science | pages=1068–70 | doi=10.1126/science.7466381| bibcode=1981Sci...211.1068K }}&lt;/ref&gt;&lt;ref&gt;{{cite journal | pmid = 7348981 | volume=105 | title=Experimental pontine and extrapontine myelinolysis | year=1980 | author=Laureno R | journal=Trans Am Neurol Assoc | pages=354–8}}&lt;/ref&gt;

Once osmotic demyelination has begun, there is no cure or specific treatment.  Care is mainly supportive.  Alcoholics are usually given vitamins to correct for other deficiencies. The favourable factors contributing to the good outcome in CPM without hyponatremia were: concurrent treatment of all electrolyte disturbances, early intensive care unit involvement at the advent of respiratory complications, early introduction of feeding including thiamine supplements with close monitoring of the electrolyte changes and input.&lt;ref name=&quot;pmid21949915&quot;/&gt;

Research has led to improved outcomes.&lt;ref name=&quot;pmid11148672&quot;&gt;{{cite journal|author=Brown WD|title=Osmotic demyelination disorders: central pontine and extrapontine myelinolysis|journal=Curr. Opin. Neurol.|volume=13|issue=6|pages=691–7|date=December 2000|pmid=11148672|doi=10.1097/00019052-200012000-00014}}&lt;/ref&gt;  Animal studies suggest that [[inositol]] reduces the severity of osmotic demyelination syndrome if given before attempting to correct chronic [[hyponatraemia]].&lt;ref&gt;{{cite journal|vauthors=Silver SM, Schroeder BM, Sterns RH, Rojiani AM | title= Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats| journal= J Neuropathol Exp Neurol| year= 2006| volume= 65| issue= 1| pages= 37–44| pmid=16410747| doi= 10.1097/01.jnen.0000195938.02292.39}}&lt;/ref&gt; Further study is required before using inositol in humans for this purpose.

==Prognosis==
Though traditionally the prognosis is considered poor, a good functional recovery is possible. All patients at risk of developing refeeding syndrome should have their electrolytes closely monitored, including sodium, potassium, magnesium, glucose and phosphate.&lt;ref name=&quot;pmid21949915&quot;/&gt; 
Recent data indicate that the prognosis of critically ill patients may even be better than what is generally considered,&lt;ref name=&quot;pmid22036854&quot;&gt;{{cite journal |vauthors=Louis G, Megarbane B, Lavoué S, Lassalle V, Argaud L, Poussel JF, Georges H, Bollaert PE |title=Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis* |journal=Critical Care Medicine |volume=40 |issue=3 |pages=970–2 |date=March 2012  |pmid=22036854 |doi=10.1097/CCM.0b013e318236f152 }}&lt;/ref&gt; despite severe initial clinical manifestations and a tendency by the intensivists to underestimate a possible favorable evolution.&lt;ref name=&quot;pmid22343870&quot;&gt;{{cite journal |author=Young GB |title=Central pontine myelinolysis: a lesson in humility* |journal=Critical Care Medicine |volume=40 |issue=3 |pages=1026–7 |date=March 2012  |pmid=22343870 |doi=10.1097/CCM.0b013e31823b8e0b }}&lt;/ref&gt;
While some patients die, most survive and of the survivors, approximately one-third recover; one-third are disabled but are able to live independently; one-third are severely disabled.&lt;ref name=&quot;pmid16210283&quot;&gt;{{cite journal|vauthors=Abbott R, Silber E, Felber J, Ekpo E |title=Osmotic demyelination syndrome|journal=BMJ|volume=331|issue=7520|pages=829–30|date=October 2005|pmid=16210283|pmc=1246086|doi=10.1136/bmj.331.7520.829|url=}}&lt;/ref&gt;  Permanent disabilities range from minor tremors and [[ataxia]] to signs of severe brain damage, such as [[spastic quadriparesis]] and [[locked-in syndrome]].&lt;ref&gt;{{cite web|last1=Luzzio|first1=Christopher|title=Central Pontine Myelinolysis|url=http://emedicine.medscape.com/article/1174329-overview|website=Medscape|accessdate=14 March 2017|date=17 November 2015}}&lt;/ref&gt; Some improvements may be seen over the course of the first several months after the condition stabilizes.

The degree of recovery depends on the extent of the original axonal damage.&lt;ref name=&quot;pmid12566274&quot;/&gt;

==References==
{{Reflist}}

== External links ==
{{Medical resources
|  ICD10           = {{ICD10|G37.2}}
|  ICD9            = &lt;!--{{ICD9|xxx}}--&gt;
|  ICDO            = 
|  OMIM            = 
|  DiseasesDB      = 
|  MedlinePlus     = 
|  eMedicineSubj   = 
|  eMedicineTopic  = 
|  MeSH            = 
|  GeneReviewsNBK  = 
|  GeneReviewsName = 
|  Orphanet        = 
}}
* [https://web.archive.org/web/20130219024253/http://rad.usuhs.mil/medpix/medpix.html?mode=image_finder&amp;srchstr=osmotic+myelinolysis&amp;search=#top MedPix] Images of Osmotic Myelinolysis

{{CNS diseases of the nervous system}}

[[Category:Demyelinating diseases of CNS]]
[[Category:Electrolyte disturbances]]</text>
      <sha1>16oxiajgrltlbhlvn43w484sdu535dq</sha1>
    </revision>
  </page>
